You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycoside Hydrolase Inhibitors

Showing 1 - 25 of 4,215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

Other Specified Hypotension, Syncope Trial in Vancouver (Acarbose, Placebo)

Completed
  • Other Specified Hypotension
  • Syncope
  • Vancouver, British Columbia, Canada
    Vancouver Coastal Health Research Institute, VGH Research Pavili
May 26, 2021

Overweight and Obesity, Type 2 Diabetes Trial in Chicago (Water, Glucose, Steviol Glycosides)

Enrolling by invitation
  • Overweight and Obesity
  • Type 2 Diabetes Mellitus
  • Water
  • +4 more
  • Naples, Florida
  • +1 more
Dec 9, 2022

Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg)

Recruiting
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • Shibīn Al Kawm, Egypt
    Menoufia University Hospital
Apr 5, 2022

The Effect of Soluble Epoxide Hydrolase (SEH) on Depression

Recruiting
  • Major Depressive Disorder
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Oct 7, 2022

    Post Traumatic Stress Disorder, Alcohol Use Disorder, Psychosis Trial in New Haven ([11C]MK-3168)

    Suspended
    • Post Traumatic Stress Disorder
    • +2 more
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Jan 24, 2022

    Healthy Trial (Nabilone Oral Capsule)

    Not yet recruiting
    • Healthy
    • Nabilone Oral Capsule
    • (no location specified)
    May 23, 2023

    Cannabis Use Disorder Trial in United States (PF 04457845, Placebo Oral Tablet)

    Recruiting
    • Cannabis Use Disorder
    • PF 04457845
    • Placebo Oral Tablet
    • New Haven, Connecticut
    • +3 more
    Feb 9, 2022

    CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

    Not yet recruiting
    • CLL/SLL
    • lisaftoclax +BTK inhibitor
    • BTK inhibitor
    • (no location specified)
    Oct 26, 2023

    Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

    Recruiting
    • Acute Myeloid Leukemia
    • Venclexta 100 MG Oral Tablet
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jun 11, 2023

    Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

    Not yet recruiting
    • Myelofibrosis
    • TQ05105 tablets
    • +2 more
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    Aug 30, 2023

    Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

    Recruiting
    • Advanced Breast Cancer
    • The combination of Dalpiciclib with physician-selected endocrine therapy
    • Chemotherapy selected by the physician
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 22, 2023

    Type 2 Diabetes Trial in Leuven (Rebaudioside A, Placebo)

    Completed
    • Type 2 Diabetes Mellitus
    • Rebaudioside A
    • Placebo
    • Leuven, Flanders, Belgium
      Centrum Clinical Pharmacology
    Apr 27, 2021

    Musculoskeletal Health in Breast Cancer During Aromatase

    Recruiting
    • Musculoskeletal Health
    • No intervention
    • Shanghai, Shanghai, China
      School of Nursing, Fudan University
    Jun 16, 2023

    SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

    Recruiting
    • Coronary Artery Disease
    • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
    • Shah Alam, Selangor, Malaysia
      Institute for Clinical Research, National Institutes of Health,
    Nov 9, 2023

    Bile Acids in Acute Insulin Resistance

    Recruiting
    • PI3K Gene Mutation
    • +4 more
    • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
    • New York, New York
      Columbia University Medical Center
    Oct 6, 2022

    ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

    Completed
    • NSCLC
    • Immune checkpoint inhibitors plus angiogenesis inhibitors
    • Immune checkpoint inhibitors without angiogenesis inhibitors
    • Suzhou, Jiangsu, China
      The Affiliated Suzhou Hospital of Nanjing Medical University
    Jan 17, 2023

    Cocaine Dependence, in Remission Trial in Rochester (AAV8-hCocH)

    Recruiting
    • Cocaine Dependence, in Remission
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 8, 2021

    Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)

    Recruiting
    • Breast Feeding
    • +3 more
    • Venipuncture
    • Leuven, Vlaams-Brabant, Belgium
      Universitaire Ziekenhuizen Leuven
    Oct 12, 2023

    Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

    Recruiting
    • Acute Esophageal Variceal Hemorrhage
    • Growth Inhibitor
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Aug 22, 2023

    Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Danville (Pharmacist co-management, CDS, Focused Education)

    Recruiting
    • Heart Failure
    • Heart Failure With Reduced Ejection Fraction
    • Pharmacist co-management
    • +2 more
    • Danville, Pennsylvania
      Geisinger Cardiology Clinics
    Aug 11, 2023

    Hepatocellular Carcinoma, Recurrence, Immune Checkpoint Inhibitor Trial in Nanning (Adjuvant tislelizumab plus lenvatinib,

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Adjuvant tislelizumab plus lenvatinib
    • Adjuvant tislelizumab
    • Nanning, China
      Jian-Hong Zhong
    Jun 11, 2023

    Gastroesophageal Reflux, Regurgitation, Heartburn Trial in Jacksonville (Breath Testing)

    Not yet recruiting
    • Gastroesophageal Reflux
    • +2 more
    • Breath Testing
    • Jacksonville, Florida
      Mayo Clinic Florida
    Jul 27, 2023

    Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

    Recruiting
    • Cancer of the Colon
    • BLOOD AND TUMOR
    • Marseille, France
      Institut Paoli Calmettes
    Jul 12, 2023

    Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

    Not yet recruiting
    • Gastric Adenocarcinoma
    • cadonilimab combined +paclitaxel (albumin-bound)
    • (no location specified)
    Nov 1, 2023